Concepedia

Luming Wu

LW

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2021

Affiliations

Lanzhou University(Current)

First Hospital of Lanzhou University

Luming Wu is an author at Lanzhou University specializing in signal transduction, endocrinology, and glucagon-like peptide-1 receptor agonists.

ORCID

Publications per year

2021–2024

3

Publications

3

Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats

Luming Wu, Yin-Xue Wang, Yin-Xue Wang et al. · Peptides · 2021 · 43 citations

, , +16

The glucagon-like peptide-1 (GLP-1) analog exenatide ameliorates intrauterine adhesions in mice

Xiaoling Ma, Yuan Ding, Luming Wu et al. · Peptides · 2021 · 18 citations

, , +14

Semaglutide May Ameliorate Fibrosis and Inhibit Epithelial–Mesenchymal Transition in Intrauterine Adhesion Models

Luming Wu, Yue Zhan, Yiqing Wang · International Journal of Molecular Sciences · 2024 · 11 citations · Full text

, , +17

1–3 of 3